 |
 |
 |
 |
 |
 |
 |
|
|
NCCN Task Force Report: Gastrointestinal Stromal Tumors (GISTs)A presentation from the NCCN 12th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™ held in Hollywood, Florida, on March 16, 2007 Presenter Margaret von Mehren, MD Faculty Disclosure Statement Dr. von Mehren has disclosed that she has financial interests, arrangements, or affiliations with the manufacturer of products and devices to be discussed in her presentation or who may financially support the educational activity. She has received honoraria for serving on advisory boards fir Pfizer Inc. and Novartis Pharmaceuticals Corporation. Dr. von Mehren has indicated that her presentation will not include discussion of investigational or unlabeled uses of a product. Program Overview The NCCN Gastrointestinal Stromal Tumors (GISTs) Task Force Report, an expansion on the NCCN Clinical Practice Guidelines in OncologyTM Soft Tissue Sarcoma, outlines the current thinking about the optimal management of patients with GIST. Based on the consensus recommendations of international experts, the task force report describes the cooperative multidisciplinary effort among medical oncology, surgery, pathology, and other specialties that is necessary to achieve the best possible results, which include reducing the incidence and risks of recurrent disease, optimizing disease control, improving quality of life by minimizing surgery that might impair function, and prolonging survival. Educational Objectives Following this activity, participants should be able to:
Intended Audience This educational activity is designed to meet the needs of physicians, nurses, and other clinical professionals who manage patients with cancer. Activity Instructions Continuing education credit will be awarded to participants who listen to the presentation and complete the evaluation. Participants should review the learning objectives and faculty disclosure statements prior to listening to a presentation in its entirety. You must be connected to the Internet in order to review and complete the evaluation form. A statement of credit will be electronically generated once you complete the evaluation form. To receive credit, this activity must be completed no later than July 27, 2008. There is no fee for participating in this activity. Accreditation Information Physicians The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians. NCCN designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Nurses This activity is approved for 0.5 contact hours. National Comprehensive Cancer Network is an approved provider of continuing nursing education by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product. Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity. Release date: July 27, 2007 Commercial Support Distribution supported by educational grants from Novartis Oncology and Pfizer, Inc.
|
|
NCCN 1st Annual Forum: Innovative Diagnostics & Therapeutics in Cancer Care™ |
|
|
